JAKing down glucocorticoids in giant cell arteritis

By afschroeder • June 15, 2025

Kermani TA, Warrington KJ. JAKing down glucocorticoids in giant cell arteritis. Med. 2025 Jun 13;6(6):100744. doi: 10.1016/j.medj.2025.100744. PMID: 40516519.

Tags: Publications, Rheumatology

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.

Chimneys

Reuben DB. Chimneys. JAMA Intern Med. 2025 Jun 23. doi: 10.1001/jamainternmed.2025.1822. Epub ahead of print. PMID: 40549397.

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]